The complement system — part of the immune system that helps defend against infections — may play a key role in age-related disease progression in multiple sclerosis (MS), according to findings from a mouse study. In fact, blocking a complement protein called C3 reduced disease severity in older mice but not in younger ones, the […]
The post ACTRIMS 2026: Blocking C3 protein seen to ease MS severity in older mice appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com